Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Apparatus and Process for Dose-Guided Radiotherapy

  • Read more about Apparatus and Process for Dose-Guided Radiotherapy
US Application 60/453,934
Filed on 2003-03-11

Method for Separating Recombinant Immunotoxin

  • Read more about Method for Separating Recombinant Immunotoxin
US Application 60/425,170
Filed on 2002-11-07

Method of Distinguishing Epithelioid Melanaoma From Fibroblastoid Melanoma

  • Read more about Method of Distinguishing Epithelioid Melanaoma From Fibroblastoid Melanoma
US Application 60/422,733
Filed on 2002-10-31

A Method to Screen Drug Libraries to Identify Drugs that Specifically Interact With Identified Proteins

  • Read more about A Method to Screen Drug Libraries to Identify Drugs that Specifically Interact With Identified Proteins
US Application 60/332,443
Filed on 2001-11-16

Immunogenic Epitopes For Fibroblast Growth Factor 5 (FGF-5) Presented By HLA-A3 And HLA-A2

  • Read more about Immunogenic Epitopes For Fibroblast Growth Factor 5 (FGF-5) Presented By HLA-A3 And HLA-A2
US Application 60/427,920
Filed on 2002-11-19

Smallpox Vaccine Regimen

  • Read more about Smallpox Vaccine Regimen
US Application 60/425,148
Filed on 2002-11-07

Method of Reducing the Activity of and Reducing the Concentration of a Mutant Kit Protein.

  • Read more about Method of Reducing the Activity of and Reducing the Concentration of a Mutant Kit Protein.
US Application 60/420,143
Filed on 2002-10-22

Applications of the HMGN1 Pathway

  • Read more about Applications of the HMGN1 Pathway
US Application 60/455,728
Filed on 2003-03-17

Device for External Movement Manipulation of Nucleic Acids and/or Proteins

  • Read more about Device for External Movement Manipulation of Nucleic Acids and/or Proteins
US Application 60/428,754
Filed on 2002-11-25

Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid

  • Read more about Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid
US Application 60/416,854
Filed on 2002-10-08

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 178
  • Page 179
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • Page 185
  • Page 186
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health